Edward W. Petrillo

1.2k total citations
26 papers, 936 citations indexed

About

Edward W. Petrillo is a scholar working on Molecular Biology, Organic Chemistry and Oncology. According to data from OpenAlex, Edward W. Petrillo has authored 26 papers receiving a total of 936 indexed citations (citations by other indexed papers that have themselves been cited), including 15 papers in Molecular Biology, 8 papers in Organic Chemistry and 6 papers in Oncology. Recurrent topics in Edward W. Petrillo's work include Chemical Synthesis and Analysis (7 papers), Protein Hydrolysis and Bioactive Peptides (6 papers) and Renin-Angiotensin System Studies (5 papers). Edward W. Petrillo is often cited by papers focused on Chemical Synthesis and Analysis (7 papers), Protein Hydrolysis and Bioactive Peptides (6 papers) and Renin-Angiotensin System Studies (5 papers). Edward W. Petrillo collaborates with scholars based in United States, Germany and Malaysia. Edward W. Petrillo's co-authors include Miguel A. Ondetti, Denis E. Ryono, Jack M. DeForrest, Charles A. Free, Katherine Rielly-Gauvin, Dinesh V. Patel, David W. Cushman, Donald S. Karanewsky, Ervin R. Spitzmiller and W. Lynn Rogers and has published in prestigious journals such as Journal of the American Chemical Society, Journal of Medicinal Chemistry and Tetrahedron.

In The Last Decade

Edward W. Petrillo

26 papers receiving 864 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Edward W. Petrillo United States 18 476 439 124 117 108 26 936
James L. Stanton Switzerland 19 483 1.0× 424 1.0× 64 0.5× 69 0.6× 114 1.1× 27 891
C. John Blankley United States 17 510 1.1× 419 1.0× 46 0.4× 43 0.4× 114 1.1× 33 1.0k
Walter Fuhrer Switzerland 13 749 1.6× 456 1.0× 127 1.0× 55 0.5× 282 2.6× 18 1.2k
Alexander Chucholowski Germany 14 670 1.4× 537 1.2× 53 0.4× 40 0.3× 89 0.8× 24 956
Natesan Murugesan United States 16 347 0.7× 463 1.1× 88 0.7× 177 1.5× 90 0.8× 31 889
Paul E. Aldrich United States 16 532 1.1× 497 1.1× 44 0.4× 27 0.2× 135 1.3× 29 1.2k
Nathan Yumibe United States 18 413 0.9× 354 0.8× 46 0.4× 165 1.4× 75 0.7× 30 1.1k
Peter Herold Switzerland 13 572 1.2× 474 1.1× 85 0.7× 38 0.3× 150 1.4× 17 905
Conrad E. Raab United States 15 356 0.7× 302 0.7× 65 0.5× 127 1.1× 21 0.2× 35 933
Hiroaki Yanagisawa Japan 17 403 0.8× 411 0.9× 42 0.3× 52 0.4× 264 2.4× 46 998

Countries citing papers authored by Edward W. Petrillo

Since Specialization
Citations

This map shows the geographic impact of Edward W. Petrillo's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Edward W. Petrillo with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Edward W. Petrillo more than expected).

Fields of papers citing papers by Edward W. Petrillo

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Edward W. Petrillo. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Edward W. Petrillo. The network helps show where Edward W. Petrillo may publish in the future.

Co-authorship network of co-authors of Edward W. Petrillo

This figure shows the co-authorship network connecting the top 25 collaborators of Edward W. Petrillo. A scholar is included among the top collaborators of Edward W. Petrillo based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Edward W. Petrillo. Edward W. Petrillo is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Herbst, John J., et al.. (2009). Multiplexing a High-Throughput Liability Assay to Leverage Efficiencies. Assay and Drug Development Technologies. 7(3). 294–303. 5 indexed citations
2.
Dickson, John K., Scott A. Biller, David R. Magnin, et al.. (1996). Orally Active Squalene Synthase Inhibitors:  Bis((acyloxy)alkyl) Prodrugs of the α-Phosphonosulfonic Acid Moiety. Journal of Medicinal Chemistry. 39(3). 661–664. 44 indexed citations
3.
Patel, Dinesh V., Katherine Rielly-Gauvin, Denis E. Ryono, et al.. (1996). ChemInform Abstract: α‐Hydroxy Phosphinyl‐Based Inhibitors of Human Renin.. ChemInform. 27(10). 5 indexed citations
4.
Patel, Dinesh V., Katherine Rielly-Gauvin, Denis E. Ryono, et al.. (1995). .alpha.-Hydroxy Phosphinyl-Based Inhibitors of Human Renin. Journal of Medicinal Chemistry. 38(22). 4557–4569. 170 indexed citations
5.
Das, Jagabandhu, Jeffrey A. Robl, Chong‐Qing Sun, et al.. (1994). Dual metalloprotease inhibitors. IV. Utilization of thiazepines and thiazines as constrained peptidomimetic surrogates in mercaptoacyl dipeptides. Bioorganic & Medicinal Chemistry Letters. 4(18). 2193–2198. 20 indexed citations
6.
Delaney, Norma G., Joel C. Barrish, Sesha Natarajan, et al.. (1994). Mercaptoacyl dipeptides as dual inhibitors of angiotensin-converting enzyme and neutral endopeptidase. Preliminary structure-activity studies. Bioorganic & Medicinal Chemistry Letters. 4(15). 1783–1788. 29 indexed citations
7.
Patel, Dinesh V., Katherine Rielly-Gauvin, Denis E. Ryono, et al.. (1993). Activated ketone based inhibitors of human renin. Journal of Medicinal Chemistry. 36(17). 2431–2447. 58 indexed citations
8.
Poss, Michael A., Charles A. Free, W. Lynn Rogers, et al.. (1993). Diol sulfonamides: A potent and novel class of inhibitors of human renin. Bioorganic & Medicinal Chemistry Letters. 3(12). 2739–2744. 4 indexed citations
9.
Hwang, Dah‐Ren, W.C. Eckelman, C.J. Mathias, et al.. (1991). Positron-labeled angiotensin-converting enzyme (ACE) inhibitor: fluorine-18-fluorocaptopril. Probing the ACE activity in vivo by positron emission tomography.. PubMed. 32(9). 1730–7. 34 indexed citations
10.
DeForrest, Jack M., et al.. (1990). Blood Pressure Lowering and Renal Hemodynamic Effects of Fosinopril in Conscious Animal Models. Journal of Cardiovascular Pharmacology. 16(1). 139–146. 7 indexed citations
11.
Karanewsky, Donald S., Michael C. Badia, David W. Cushman, et al.. (1990). (Phosphinyloxy)acyl amino acid inhibitors of angiotensin converting enzyme. 2. Terminal amino acid analogs of (S)-1-[6-amino-2-[[hydroxy(4-phenylbutyl)phosphinyl]oxy]-1-oxohexyl]-L-proline. Journal of Medicinal Chemistry. 33(5). 1459–1469. 18 indexed citations
12.
Waldron, Thomas L., et al.. (1989). Preclinical Pharmacology of Zofenopril, an Inhibitor of Angiotensin I Converting Enzyme. Journal of Cardiovascular Pharmacology. 13(6). 887–894. 29 indexed citations
13.
Waldron, Thomas L., et al.. (1989). Fosinopril, a Phosphinic Acid Inhibitor of Angiotensin I Converting Enzyme: In Vitro and Preclinical In Vivo Pharmacology. Journal of Cardiovascular Pharmacology. 14(5). 730–736. 37 indexed citations
14.
Karanewsky, Donald S., Michael C. Badia, David W. Cushman, et al.. (1988). (Phosphinyloxy)acyl amino acid inhibitors of angiotensin converting enzyme (ACE). 1. Discovery of (S)-1-[6-amino-2-[[hydroxy(4-phenylbutyl)phosphinyl]oxy]-1-oxohexyl]-L-proline, a novel orally active inhibitor of ACE. Journal of Medicinal Chemistry. 31(1). 204–212. 82 indexed citations
15.
Cushman, David W., Miguel A. Ondetti, Eric M. Gordon, et al.. (1987). Rational Design and Biochemical Utility of Specific Inhibitors of Angiotensin-Converting Enzyme. Journal of Cardiovascular Pharmacology. 10. 17–30. 37 indexed citations
16.
Petrillo, Edward W., J.R. Powell, David W. Cushman, & Miguel A. Ondetti. (1987). Angiotensin-Converting Enzyme Inhibitors: Accomplishments and Challenges. Clinical and Experimental Hypertension Part A Theory and Practice. 9(2-3). 235–241. 7 indexed citations
17.
Petrillo, Edward W. & Miguel A. Ondetti. (1982). Angiotensin‐converting enzyme inhibitors: Medicinal chemistry and biological actions. Medicinal Research Reviews. 2(1). 1–41. 156 indexed citations
18.
Petrillo, Edward W. & Ervin R. Spitzmiller. (1979). Synthesis of 2-phosphonopyrrolidine and its substitution for proline in an inhibitor of angiotensin-converting enzyme. Tetrahedron Letters. 20(51). 4929–4930. 39 indexed citations
19.
Berson, Jerome A., Edward W. Petrillo, & Paul Bickart. (1974). Cycloreversions of diazabicyclo[4.2.0]octenes. Test of the bent bond requirement for concert. Journal of the American Chemical Society. 96(2). 636–637. 7 indexed citations
20.
Jones, Maitland & Edward W. Petrillo. (1969). - and -1,2-Dimethylspiro[2.6]nona-4,6,8-triene. Tetrahedron Letters. 10(45). 3953–3956. 5 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by James L. Stanton Breakdown of academic impact, for papers by C. John Blankley Breakdown of academic impact, for papers by Walter Fuhrer Breakdown of academic impact, for papers by Alexander Chucholowski Breakdown of academic impact, for papers by Natesan Murugesan Breakdown of academic impact, for papers by Paul E. Aldrich Breakdown of academic impact, for papers by Nathan Yumibe Breakdown of academic impact, for papers by Peter Herold Breakdown of academic impact, for papers by Conrad E. Raab Breakdown of academic impact, for papers by Hiroaki Yanagisawa
Rankless by CCL
2026